Sobredosis de opioides en el trabajo, una realidad que empleadores ignoran
En ciertas industrias, como la de la construcción, el consumo de opioides es una constante con la que pocos empleadores están preparados para lidiar.
Workers Overdose On The Job, And Employers Struggle To Respond
Despite the growing epidemic of Americans misusing opioids and overdosing on the job, many employers turn a blind eye to addiction within their workforce — ill-equipped or unwilling to confront an issue they are at a loss to handle.
Half As Many People Are Trying Heroin, But Marijuana Use Grows
An annual government survey of drug use and health shows a dramatic drop in the number of people who tried heroin but an uptick in pot use.
Los pediatras son claros: no se debe mezclar marihuana y embarazo
La Academia Americana de Pediatría cita creciente evidencia del daño potencial de la marihuana para el desarrollo a largo plazo de los niños.
Pediatricians Put It Bluntly: Motherhood And Marijuana Don’t Mix
Women who are pregnant or breastfeeding should not use marijuana because of serious concerns about neurological consequences for children, the American Academy of Pediatrics said on Monday.
A Baby Was Treated With A Nap And A Bottle Of Formula. The Bill Was $18,000.
An ER patient can be charged thousands of dollars in “trauma fees” — even if they weren’t treated for trauma.
Graphic: Opioid Painkiller Is Top Prescription In 10 States
Though opioid prescriptions appear to be on the decline, Vicodin and Norco remain popular, especially in the South. In more than half of states, Synthroid — a drug to treat hypothyroidism — came in at No. 1.
Reporter’s Notebook: The Tale Of Theranos And The Mysterious Fire Alarm
Health care tech startup Theranos was riding high back in 2014. But when a reporter raised questions, its media reps circled the wagons.
Opioid Maker Funds Efforts To Fight Addiction: Is It ‘Blood Money’ Or Charity?
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it — or at least salvage its own reputation.
Of ‘Miracles’ And Money: Why Hemophilia Drugs Are So Expensive
The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn’t worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.